2026
Go

Health Care : Pharmaceuticals | Large Cap Value

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The Company's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.

Closing Price: $52.31

Day's Change: -0.12 (-0.23%)

Bid: --

Ask: --

B/A Size: --

Day's High: 52.37

Day's Low: 51.25

Volume (Light) Volume: 16,143,272 10-day average volume: 22,369,252: 16,143,272

Yesterday's News, July 01, 2022
9:31 am ET	Thinking about trading options or stock in Pfizer, Valero Energy, General Mills, Phillips 66, or Tesla? InvestorsObserver issues critical PriceWatch Alerts for PFE, VLO, GIS, PSX, and TSLA. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)
June 30, 2022
10:30 am ET	Thinking about trading options or stock in Advanced Micro Devices, Netflix, Pfizer, General Motors, or Target? InvestorsObserver issues critical PriceWatch Alerts for AMD, NFLX, PFE, GM, and TGT. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)
6:45 am ET	Pfizer Announces Submission of New Drug Application to the U.S. FDA for PAXLOVID(TM) Pfizer Inc. (NYSE: PFE) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of PAXLOVID(TM) (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) for patients who are at...(BusinessWire)
June 29, 2022
4:45 pm ET	Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine - 105 million 30 ug, 10 ug and 3 ug doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses NEW YORK and MAINZ, GERMANY, JUNE 29, 2022 -- Pfizer Inc. (NYSE: PFE) and BioNTech SE...(Thomson Reuters ONE)
4:45 pm ET	Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new vaccine supply agreement with the U.S. government to support the continued fight against COVID-19. Under the agreement, the U.S. government will receive 105 million doses...(BusinessWire)
June 28, 2022
6:00 am ET	Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus EQNX::TICKER_START (NasdaqGM:ROIV),(NasdaqGM:ROIVW),(NYSE:PFE), EQNX::TICKER_END Roivant Sciences and Pfizer today announced the unveiling of Priovant Therapeutics, dedicated to developing and commercializing novel therapies for autoimmune diseases...(Globe Newswire)
6:00 am ET	Roivant and Pfizer Unveil Priovant Therapeutics and Ongoing Registrational Studies for Oral Brepocitinib in Dermatomyositis and Lupus Roivant Sciences and Pfizer today announced the unveiling of Priovant Therapeutics, dedicated to developing and commercializing novel therapies for autoimmune diseases with the greatest morbidity and mortality. Priovant was established in September...(BusinessWire)
June 25, 2022
10:00 am ET	Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive data evaluating the safety, tolerability, and immunogenicity of two Omicron-adapted COVID-19 vaccine candidates: one monovalent and the other bivalent, a combination of...(BusinessWire)
June 24, 2022
10:00 am ET	Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Thursday, July 28, 2022. The purpose of the call is to provide an update on Pfizer's...(BusinessWire)
June 23, 2022
10:35 am ET	Pfizer Declares Third-Quarter 2022 Dividend Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.40 third-quarter 2022 dividend on the company's common stock, payable September 6, 2022, to holders of the Common Stock of record at the close of business on July 29...(BusinessWire)
June 22, 2022
9:31 am ET	Thinking about trading options or stock in Humana, Walt Disney, Apple, Pfizer, or Starbucks? InvestorsObserver issues critical PriceWatch Alerts for HUM, DIS, AAPL, PFE, and SBUX. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)
June 21, 2022
9:40 am ET	Thinking about trading options or stock in Apple, Bank of America, Tesla, Microsoft, or Pfizer? InvestorsObserver issues critical PriceWatch Alerts for AAPL, BAC, TSLA, MSFT, and PFE. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)
June 20, 2022
1:00 am ET	Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15 Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today announced that they have entered into an Equity Subscription Agreement and have updated the terms of their Collaboration and License...(BusinessWire)
June 17, 2022
10:45 am ET	Thinking about trading options or stock in Apple, Bank of America, Tesla, Microsoft, or Pfizer? InvestorsObserver issues critical PriceWatch Alerts for AAPL, BAC, TSLA, MSFT, and PFE. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)
9:24 am ET	Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine as a three 3-ug dose series for children 6 months...(BusinessWire)
6:45 am ET	Myovant Sciences and Pfizer Announce Publication in The Lancet of Phase 3 SPIRIT 1 and SPIRIT 2 Studies of Once-Daily Relugolix Combination Therapy in Women With Endometriosis-Associated Pain EQNX::TICKER_START (NYSE:MYOV),(NYSE:PFE), EQNX::TICKER_END Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced that results of the Phase 3 SPIRIT 1 and SPIRIT 2 studies of investigational once-daily relugolix combination...(Globe Newswire)
June 16, 2022
9:31 am ET	Thinking about trading options or stock in Twitter, Netflix, Apple, Advanced Micro Devices, or Pfizer? InvestorsObserver issues critical PriceWatch Alerts for TWTR, NFLX, AAPL, AMD, and PFE. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)
7:00 am ET	Akero Therapeutics Announces Two Financing Transactions with Pfizer Inc. and Hercules Capital, Inc. Providing Access to Up To $125 Million EQNX::TICKER_START (NASDAQ:AKRO),(NYSE:PFE),(NYSE:HTGC), EQNX::TICKER_END $25 Million Equity Investment by Pfizer at $9.90 Per Share Term Loan Facility from Hercules Providing Up to $100 Million If Fully Drawn, Akero Cash Runway Extended One Full...(Globe Newswire)
June 14, 2022
4:30 pm ET	Pfizer Reports Additional Data on PAXLOVID(TM) Supporting Upcoming New Drug Application Submission to U.S. FDA Pfizer Inc. (NYSE: PFE) today shared data from the Phase 2/3 EPIC-SR (Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients) study evaluating the use of PAXLOVID(TM) (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) in...(BusinessWire)
June 13, 2022
9:31 am ET	Thinking about trading options or stock in Apple, Microsoft, Walt Disney, Pfizer, or Alibaba? InvestorsObserver issues critical PriceWatch Alerts for AAPL, MSFT, DIS, PFE, and BABA. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)
Next >

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and